Research News

Aiming to slash the prevalence of violence-borne diarrhoea, the health ministry on Saturday launched the Rota Virus vaccine here, which will be available free of cost at public healthcare facilities, initially in four states.

We are often ignorant about loss of teeth but preserving oral health can benefit you in a longer run. According to researchers, loss of teeth is linked to increased risk for cognitive impairment and dementia in adults.

What has brain to do with glucose metabolism? A lot, say researchers, suggesting that not just your pancreas, a group of neurons in the hypothalamus area also plays a vital role in maintaining blood glucose levels.

Spending on programmes to control India’s three main communicable diseases malaria, tuberculosis and leprosy increased seven percent over five years while cases reported, taken together, increased 32 percent, according to an IndiaSpend analysis of government data.

Malaria, a life-threatening disease caused by parasites that are transmitted to people through mosquitoe bites, started out as a parasite in birds, and then it evolved to colonise bats, and from there it has evolved to affect other mammals, reveals a new study.

The Reston virus, a member of the Ebola virus family which is known to circulate in domestic pigs in Asia, may acquire the few mutations necessary to cause disease in humans and to develop into a novel health threat, researchers have warned.

Administration of three or more courses of antibiotics before a child reaches the age of two is linked to increased risk of early childhood obesity, says a new study.

With the government announcing eradication of tuberculosis by 2030, a doctor has says a new 'Endobroncial Ultrasound' medical process that was introduced in India recently can contribute in faster diagnosis of the disease leading to correct treatment on time.

Swedish researchers have found that laser light can be used to examine the lungs of premature babies without exposing them to X-ray radiation, which can prove to be much harmful.

The cost of treating Hepatitis C virus (HCV) could be reduced by half if doctors are trained to predict when a patient can safely stop taking the expensive but effective direct-acting antiviral (DAA) medication, suggests new research.